Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Oktober 2022

Genmab — Oktober 2022

Planlagt Fastgjort Låst Flyttet Genmab
641 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • H Offline
    H Offline
    henrik48
    wrote on sidst redigeret af
    #584

    Mon der bliver rødvin til,Pensionisten til aften 🙂

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #585

      Man kan jo sænke forventningerne til 2850 for at være på den sikre side

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #586

        congress.esgo
        1392
        Tisotumab Vedotin Combinations with Pembrolizumab or Carboplatin in Patients With Recurrent/Metastatic Cervical Cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205

        1. Cervical cancer Domenica Lorusso Italy Oral poster session 3 , 28 Oct 15:45-16:45
        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #587

          not sure if they will
          present anyting new

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #588

            there is also a poster - 1548
            Trial in Progress Update on ENGOT-cx8/GOG-3024/innovaTV 205:
            Addition of a New Cohort Using First-Line Tisotumab Vedotin +
            Pembrolizumab + Carboplatin ± Bevacizumab in

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #589

              EPCO....!

              1 Reply Last reply
              0
              • D Offline
                D Offline
                deleted-user
                wrote on sidst redigeret af
                #590

                Tæller det som en god fredagsnyhed?

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #591

                  https://ir.genmab.com/news-releases/news-release-details/genmab-announces-submissions-regulatory-applications-epcoritamab Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) Forventet inden 31/12 🙂

                  1 Reply Last reply
                  0
                  • DarvinD Offline
                    DarvinD Offline
                    Darvin
                    wrote on sidst redigeret af
                    #592

                    Skal vi ikke bare sige ja - og glæde os til fyraften

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #593

                      En FDA ansøgning af Genmab mens EMA har accepteret Abbvie ansøgning

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #594

                        accepteret = "validated" - op til egen fortolkning

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #595

                          excellent! maybe AbbVie will confirm that accepted
                          in their Q3 call this afternoon

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #596

                            Kanon. Casen yderligere derisket

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #597

                              Og så før lukketid - skønt.

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #598

                                Så bliver der rødvin til Pensionisten

                                1 Reply Last reply
                                0
                                • StockBullS Offline
                                  StockBullS Offline
                                  StockBull
                                  wrote on sidst redigeret af
                                  #599

                                  som jeg lige husker har FDA 60 dage til at acceptere ansøgningen og det vil vel sige Genmab kan modtage deres milestone betaling senest 28 dec.

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #600

                                    så er spørgsmålet bare hvor stor betalingen bliver

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #601

                                      God fredagsnyhed 🙂

                                      1 Reply Last reply
                                      0
                                      • K Offline
                                        K Offline
                                        kkjoel
                                        wrote on sidst redigeret af
                                        #602

                                        Lækkert transatlantisk koncept til efterfølgelse.. de søger i hinandens forhaver.. og koordinerer GENs annoncering af sin indgivning af ansøgning til FDA - med AbbVies bekræftelse på at EMA har valideret deres ansøgning. Rigtig sjovt one-two punch.

                                        1 Reply Last reply
                                        0
                                        • K Offline
                                          K Offline
                                          kkjoel
                                          wrote on sidst redigeret af
                                          #603

                                          Fra AbbVie PM, i samme punkt: "European Medicines Agency (EMA) validates AbbVie's Marketing Authorization Application; Genmab submits Biologics License Application to U.S. Food and Drug Administration (FDA)"

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper